These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 20555086)

  • 1. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Oberg K; Akerström G; Rindi G; Jelic S;
    Ann Oncol; 2010 May; 21 Suppl 5():v223-7. PubMed ID: 20555086
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Oberg K; Jelic S;
    Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Oberg K; Hellman P; Kwekkeboom D; Jelic S;
    Ann Oncol; 2010 May; 21 Suppl 5():v220-2. PubMed ID: 20555085
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
    Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
    Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.
    Oberg K; Jelic S;
    Ann Oncol; 2009 May; 20 Suppl 4():150-3. PubMed ID: 19454440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET)].
    Kos-Kudła B;
    Endokrynol Pol; 2006; 57(3):267-72. PubMed ID: 17111342
    [No Abstract]   [Full Text] [Related]  

  • 7. Current Concepts in the Management of GEP-NETs: Introduction.
    Iyer R
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):3-4. PubMed ID: 27167990
    [No Abstract]   [Full Text] [Related]  

  • 8. [More attention should be paid to the understanding of gastroenteropancreatic neuroendocrine tumors].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):158-60. PubMed ID: 22780939
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guidelines for gastroenteropancreatic neuroendocrine tumors--what is new? What should be incorporated in daily therapeutic decisions?].
    Grabowski P; Hörsch D
    Z Gastroenterol; 2015 Oct; 53(10):1194-200. PubMed ID: 26480056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
    Janson ET; Sørbye H; Welin S; Federspiel B; Grønbaek H; Hellman P; Mathisen O; Mortensen J; Sundin A; Thiis-Evensen E; Välimäki MJ; Oberg K; Knigge U
    Acta Oncol; 2010 Aug; 49(6):740-56. PubMed ID: 20553100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Localization diagnostics of neuroendocrine gastrointestinal tumours].
    Kjaer A; Knigge U; Mortensen J; Hansen CP; Fallentin E
    Ugeskr Laeger; 2010 Oct; 172(43):2953-6. PubMed ID: 21040674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine tumors of the gastroenteropancreatic system. An interdisciplinary challenge].
    Beuschlein F; Reincke M
    Internist (Berl); 2012 Feb; 53(2):129-30. PubMed ID: 22457878
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system].
    Hörsch D; Sayeg Y; Bonnet R; Kaemmerer D; Presselt N; Baum RP
    Pneumologie; 2012 Jan; 66(1):44-8. PubMed ID: 22250054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroenteropancreatic neuroendocrine tumors. Where are we now?
    Castellano D
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():1. PubMed ID: 21365184
    [No Abstract]   [Full Text] [Related]  

  • 15. New directions in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): shifting from symptom management to targeting tumors.
    Weber M
    Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):12-7. PubMed ID: 25768104
    [No Abstract]   [Full Text] [Related]  

  • 16. Cases in the Management of GEP-NETs: The Use of Surgery, an Underutilized Option in the Management of Advanced-Stage NETs.
    Boudreaux JP
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):7-11. PubMed ID: 27167992
    [No Abstract]   [Full Text] [Related]  

  • 17. The diagnosis and medical management of advanced neuroendocrine tumors.
    Kaltsas GA; Besser GM; Grossman AB
    Endocr Rev; 2004 Jun; 25(3):458-511. PubMed ID: 15180952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.
    Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
    Acta Oncol; 2004; 43(7):617-25. PubMed ID: 15545182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Öberg K; Knigge U; Kwekkeboom D; Perren A;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii124-30. PubMed ID: 22997445
    [No Abstract]   [Full Text] [Related]  

  • 20. Cases in the Management of GEP-NETs: Combination Regimens.
    Braiteh F
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):11-3. PubMed ID: 27167993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.